Financial Gravity Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Financial Gravity Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	18	–	–	﹤0.01%	980
2025 Q4	$0	Hold	18	–	–	﹤0.01%	957
2025 Q3	$0	Buy	+18	New	–	﹤0.01%	972
2025 Q1	$0	Buy	+18	New	–	﹤0.01%	1055

Other funds holding SRNE

VWA

VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Oakworth Capital Birmingham, Alabama $2.1B AUM 24.07% 1-Year Est. Return

Financial Gravity Asset Management's SRNE Position: Q1 2026 in Review

Financial Gravity Asset Management held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q1 2026 at 18 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #980.

Financial Gravity Asset Management first reported a position in SRNE in Q1 2025 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold SRNE as of Q1 2026.

Financial Gravity Asset Management held 18 shares of Sorrento Therapeutics, Inc. worth $0 as of Q1 2026.
Financial Gravity Asset Management left its Sorrento Therapeutics, Inc. share count unchanged in Q1 2026.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2026, its #980 holding.
Financial Gravity Asset Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2025 and has held it in 4 quarters since.
4 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2026.

Based on Financial Gravity Asset Management's 13F filing for Q1 2026, filed 8 May 2026.